Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sehested

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Cancer|February 15, 1986
Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patientsM Sehested, F R Hirsch, K Osterlind, et al.
British Journal of Cancer|February 1, 1993
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cellsE Friche, E J Demant, M Sehested, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancerB S Nielsen, M Sehested, S Timshel, et al.
Blood|February 1, 1995
Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiationN Borregaard, M Sehested, B S Nielsen, et al.
Biochemical Pharmacology|January 15, 1991
Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changesP Bouchelouche, E Friche, M Sehested, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Transplantation Proceedings|February 1, 1993
Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patientsC B Andersen, T Horn, M Sehested, et al.
European Journal of Respiratory Diseases|January 1, 1981
Histological examination for Z-gene alpha 1-antitrypsin deficiency in small cell anaplastic carcinoma of the lungM Sehested, F R Hirsch, K Hou-Jensen, et al.
Biochemical Pharmacology|September 15, 1989
Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cellsM Sehested, N Bindslev, E J Demant, et al.
British Journal of Cancer|January 1, 1997
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabinP B Jensen, B Holm, M Sorensen, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cancer|February 15, 1986
Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patientsM Sehested, F R Hirsch, K Osterlind, et al.
British Journal of Cancer|February 1, 1993
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cellsE Friche, E J Demant, M Sehested, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancerB S Nielsen, M Sehested, S Timshel, et al.
Blood|February 1, 1995
Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiationN Borregaard, M Sehested, B S Nielsen, et al.
Biochemical Pharmacology|January 15, 1991
Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changesP Bouchelouche, E Friche, M Sehested, et al.
Cancer Treatment Reviews|January 25, 2000
Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratoryP B Jensen, M Sehested, S W Langer, et al.
Transplantation Proceedings|February 1, 1993
Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patientsC B Andersen, T Horn, M Sehested, et al.
European Journal of Respiratory Diseases|January 1, 1981
Histological examination for Z-gene alpha 1-antitrypsin deficiency in small cell anaplastic carcinoma of the lungM Sehested, F R Hirsch, K Hou-Jensen, et al.
Biochemical Pharmacology|September 15, 1989
Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cellsM Sehested, N Bindslev, E J Demant, et al.
British Journal of Cancer|January 1, 1997
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabinP B Jensen, B Holm, M Sorensen, et al.
Pageof 10